Using a Simple Blood Test Helps Detecting Cancer Earlier Than Ever...

Tumor biopsies represent the standard for cancer diagnosis. They are the primary method for molecular testing designed to guide the...

A Low-Fat Diet Helps Reduce Risk of Death From Breast Cancer...

The Women’s Health Initiative (WHI) clinical trial of dietary modification in nearly 49,000 postmenopausal women with no previous history of breast...

While Oncologists’ Pay Attention to Patients’ Weight Management and Diet they...

A new study published today in the Journal of Oncology Practice (JOP) shows findings of a 2018 American Society of Clinical Oncology (ASCO) Oncology Workforce...

Pfizer to Showcase Data from Innovative Science at 2019 Annual ASCO...

Data from 10 therapies across 10 types of cancer mechanisms of action highlighting Pfizer’s cutting-edge approach, expertise in precision medicine and work...

Study Shows Some Elderly Cancer Survivors may Face Risk of Brain...

A study funded, in part through support to the Central Brain Tumor Registry of the United States, confirms that Elderly survivors of...

Clinical Trial Finds More Targetable Genetic Alterations in Pediatric Cancers

At the launch of the National Cancer Institute-Children’s Oncology Group Pediatric Molecular Analysis for Therapy Choice (NCI-COG Pediatric MATCH) trial in 2017,...

Entrectinib Benefits Children and Adolescents with CNS and Other Cancers That...

In a phase I/IB study of 29 patients, age 4.9 months to 20 years, with rare central nervous system (CNS) tumors,...

Lenalidomide Significantly Reduces the Risk of Smoldering Multiple Myeloma from Progressing

The phase II/III E3A06 randomized clinical trial (NCT01169337), funded by the National Institutes of Health (NIH), found that lenalidomide (Revlimid®; Celgene), significantly...

Sanofi’s Oncology Targets Highlighted at Annual ASCO Meeting

During the upcoming annual meeting American Society of Clinical Oncology (ASCO) in June 2019, Sanofi's oncology franchise will present a renewed strategy...

Smoking Cessation Associated with Lower Risk of Bladder Cancer in Postmenopausal...

A large study of postmenopausal women funded by the National Heart, Lung, and Blood Institute, the National Institutes of Health, and the...